Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Circulating Tumor Cells (CTC) Liquid Biopsy market size is projected to grow from US$ 1071.2 million in 2022 to US$ 2715.5 million in 2029; it is expected to grow at a CAGR of 14.2% from 2023 to 2029.
North America dominates global circulating tumor cells (CTC) liquid biopsy market. This is majorly due to the growing adoption of the liquid biopsy in the North American region for diagnosis of cancer. There are rapidly growing cases of cancer in US which has contributed in the dominance of North America in the global liquid biopsy market.
LPI (LP Information)' newest research report, the “Circulating Tumor Cells (CTC) Liquid Biopsy Industry Forecast” looks at past sales and reviews total world Circulating Tumor Cells (CTC) Liquid Biopsy sales in 2022, providing a comprehensive analysis by region and market sector of projected Circulating Tumor Cells (CTC) Liquid Biopsy sales for 2023 through 2029. With Circulating Tumor Cells (CTC) Liquid Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circulating Tumor Cells (CTC) Liquid Biopsy industry.
This Insight Report provides a comprehensive analysis of the global Circulating Tumor Cells (CTC) Liquid Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Circulating Tumor Cells (CTC) Liquid Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Circulating Tumor Cells (CTC) Liquid Biopsy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circulating Tumor Cells (CTC) Liquid Biopsy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circulating Tumor Cells (CTC) Liquid Biopsy.
This report presents a comprehensive overview, market shares, and growth opportunities of Circulating Tumor Cells (CTC) Liquid Biopsy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The global Circulating Tumor Cells (CTC) Liquid Biopsy market size is projected to grow from US$ 1071.2 million in 2022 to US$ 2715.5 million in 2029; it is expected to grow at a CAGR of 14.2% from 2023 to 2029.
North America dominates global circulating tumor cells (CTC) liquid biopsy market. This is majorly due to the growing adoption of the liquid biopsy in the North American region for diagnosis of cancer. There are rapidly growing cases of cancer in US which has contributed in the dominance of North America in the global liquid biopsy market.
LPI (LP Information)' newest research report, the “Circulating Tumor Cells (CTC) Liquid Biopsy Industry Forecast” looks at past sales and reviews total world Circulating Tumor Cells (CTC) Liquid Biopsy sales in 2022, providing a comprehensive analysis by region and market sector of projected Circulating Tumor Cells (CTC) Liquid Biopsy sales for 2023 through 2029. With Circulating Tumor Cells (CTC) Liquid Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circulating Tumor Cells (CTC) Liquid Biopsy industry.
This Insight Report provides a comprehensive analysis of the global Circulating Tumor Cells (CTC) Liquid Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Circulating Tumor Cells (CTC) Liquid Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Circulating Tumor Cells (CTC) Liquid Biopsy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circulating Tumor Cells (CTC) Liquid Biopsy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circulating Tumor Cells (CTC) Liquid Biopsy.
This report presents a comprehensive overview, market shares, and growth opportunities of Circulating Tumor Cells (CTC) Liquid Biopsy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Kits & Reagents
- Blood Collection Tubes
- Devices
- Research & Academic Institutes
- Hospitals
- Physician Laboratories
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- QIAGEN
- Bio-Techne
- Precision Medical
- Aviva Systems Biological
- Biocept
- Fluxion Biosciences
- Greiner Bio-One International GmbH
- Ikonisys
- Miltenyi Biotec
- IVDiagnostics
- BioFluidica
- Canopus Medical
- Biolidics
- Creativ MicroTech
- LungLife AI
- Epic Sciences
- Rarecells Diagnostics
- ScreenCell
- Menarini Silicon Biosystems
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2018-2029
2.1.2 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Circulating Tumor Cells (CTC) Liquid Biopsy Segment by Type
2.2.1 Kits & Reagents
2.2.2 Blood Collection Tubes
2.2.3 Devices
2.3 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type
2.3.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2023)
2.4 Circulating Tumor Cells (CTC) Liquid Biopsy Segment by Application
2.4.1 Research & Academic Institutes
2.4.2 Hospitals
2.4.3 Physician Laboratories
2.4.4 Others
2.5 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application
2.5.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2018-2023)
3 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET SIZE BY PLAYER
3.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Players
3.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Players (2018-2023)
3.1.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Players (2018-2023)
3.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY BY REGIONS
4.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Regions (2018-2023)
4.2 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth (2018-2023)
4.3 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth (2018-2023)
4.4 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth (2018-2023)
4.5 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2018-2023)
5.2 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023)
5.3 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2018-2023)
6.2 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023)
6.3 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Circulating Tumor Cells (CTC) Liquid Biopsy by Country (2018-2023)
7.2 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023)
7.3 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy by Region (2018-2023)
8.2 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023)
8.3 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET FORECAST
10.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Regions (2024-2029)
10.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Regions (2024-2029)
10.1.2 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.1.3 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.1.4 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.1.5 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.2 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Country (2024-2029)
10.2.1 United States Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.2.2 Canada Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.2.3 Mexico Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.2.4 Brazil Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.3 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Region (2024-2029)
10.3.1 China Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.3.2 Japan Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.3.3 Korea Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.3.4 Southeast Asia Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.3.5 India Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.3.6 Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.4 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Country (2024-2029)
10.4.1 Germany Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.4.2 France Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.4.3 UK Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.4.4 Italy Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.4.5 Russia Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.5 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Region (2024-2029)
10.5.1 Egypt Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.5.2 South Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.5.3 Israel Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.5.4 Turkey Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.5.5 GCC Countries Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.6 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Type (2024-2029)
10.7 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 QIAGEN
11.1.1 QIAGEN Company Information
11.1.2 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.1.3 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 QIAGEN Main Business Overview
11.1.5 QIAGEN Latest Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Company Information
11.2.2 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.2.3 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Bio-Techne Main Business Overview
11.2.5 Bio-Techne Latest Developments
11.3 Precision Medical
11.3.1 Precision Medical Company Information
11.3.2 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.3.3 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Precision Medical Main Business Overview
11.3.5 Precision Medical Latest Developments
11.4 Aviva Systems Biological
11.4.1 Aviva Systems Biological Company Information
11.4.2 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.4.3 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Aviva Systems Biological Main Business Overview
11.4.5 Aviva Systems Biological Latest Developments
11.5 Biocept
11.5.1 Biocept Company Information
11.5.2 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.5.3 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Biocept Main Business Overview
11.5.5 Biocept Latest Developments
11.6 Fluxion Biosciences
11.6.1 Fluxion Biosciences Company Information
11.6.2 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.6.3 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Fluxion Biosciences Main Business Overview
11.6.5 Fluxion Biosciences Latest Developments
11.7 Greiner Bio-One International GmbH
11.7.1 Greiner Bio-One International GmbH Company Information
11.7.2 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.7.3 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Greiner Bio-One International GmbH Main Business Overview
11.7.5 Greiner Bio-One International GmbH Latest Developments
11.8 Ikonisys
11.8.1 Ikonisys Company Information
11.8.2 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.8.3 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Ikonisys Main Business Overview
11.8.5 Ikonisys Latest Developments
11.9 Miltenyi Biotec
11.9.1 Miltenyi Biotec Company Information
11.9.2 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.9.3 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Miltenyi Biotec Main Business Overview
11.9.5 Miltenyi Biotec Latest Developments
11.10 IVDiagnostics
11.10.1 IVDiagnostics Company Information
11.10.2 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.10.3 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 IVDiagnostics Main Business Overview
11.10.5 IVDiagnostics Latest Developments
11.11 BioFluidica
11.11.1 BioFluidica Company Information
11.11.2 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.11.3 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 BioFluidica Main Business Overview
11.11.5 BioFluidica Latest Developments
11.12 Canopus Medical
11.12.1 Canopus Medical Company Information
11.12.2 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.12.3 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Canopus Medical Main Business Overview
11.12.5 Canopus Medical Latest Developments
11.13 Biolidics
11.13.1 Biolidics Company Information
11.13.2 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.13.3 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Biolidics Main Business Overview
11.13.5 Biolidics Latest Developments
11.14 Creativ MicroTech
11.14.1 Creativ MicroTech Company Information
11.14.2 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.14.3 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Creativ MicroTech Main Business Overview
11.14.5 Creativ MicroTech Latest Developments
11.15 LungLife AI
11.15.1 LungLife AI Company Information
11.15.2 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.15.3 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 LungLife AI Main Business Overview
11.15.5 LungLife AI Latest Developments
11.16 Epic Sciences
11.16.1 Epic Sciences Company Information
11.16.2 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.16.3 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Epic Sciences Main Business Overview
11.16.5 Epic Sciences Latest Developments
11.17 Rarecells Diagnostics
11.17.1 Rarecells Diagnostics Company Information
11.17.2 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.17.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Rarecells Diagnostics Main Business Overview
11.17.5 Rarecells Diagnostics Latest Developments
11.18 ScreenCell
11.18.1 ScreenCell Company Information
11.18.2 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.18.3 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 ScreenCell Main Business Overview
11.18.5 ScreenCell Latest Developments
11.19 Menarini Silicon Biosystems
11.19.1 Menarini Silicon Biosystems Company Information
11.19.2 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.19.3 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Menarini Silicon Biosystems Main Business Overview
11.19.5 Menarini Silicon Biosystems Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2018-2029
2.1.2 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Circulating Tumor Cells (CTC) Liquid Biopsy Segment by Type
2.2.1 Kits & Reagents
2.2.2 Blood Collection Tubes
2.2.3 Devices
2.3 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type
2.3.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2023)
2.4 Circulating Tumor Cells (CTC) Liquid Biopsy Segment by Application
2.4.1 Research & Academic Institutes
2.4.2 Hospitals
2.4.3 Physician Laboratories
2.4.4 Others
2.5 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application
2.5.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2018-2023)
3 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET SIZE BY PLAYER
3.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Players
3.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Players (2018-2023)
3.1.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Players (2018-2023)
3.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY BY REGIONS
4.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Regions (2018-2023)
4.2 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth (2018-2023)
4.3 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth (2018-2023)
4.4 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth (2018-2023)
4.5 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2018-2023)
5.2 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023)
5.3 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2018-2023)
6.2 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023)
6.3 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Circulating Tumor Cells (CTC) Liquid Biopsy by Country (2018-2023)
7.2 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023)
7.3 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy by Region (2018-2023)
8.2 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023)
8.3 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET FORECAST
10.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Regions (2024-2029)
10.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Regions (2024-2029)
10.1.2 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.1.3 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.1.4 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.1.5 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.2 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Country (2024-2029)
10.2.1 United States Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.2.2 Canada Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.2.3 Mexico Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.2.4 Brazil Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.3 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Region (2024-2029)
10.3.1 China Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.3.2 Japan Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.3.3 Korea Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.3.4 Southeast Asia Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.3.5 India Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.3.6 Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.4 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Country (2024-2029)
10.4.1 Germany Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.4.2 France Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.4.3 UK Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.4.4 Italy Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.4.5 Russia Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.5 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Region (2024-2029)
10.5.1 Egypt Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.5.2 South Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.5.3 Israel Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.5.4 Turkey Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.5.5 GCC Countries Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.6 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Type (2024-2029)
10.7 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 QIAGEN
11.1.1 QIAGEN Company Information
11.1.2 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.1.3 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 QIAGEN Main Business Overview
11.1.5 QIAGEN Latest Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Company Information
11.2.2 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.2.3 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Bio-Techne Main Business Overview
11.2.5 Bio-Techne Latest Developments
11.3 Precision Medical
11.3.1 Precision Medical Company Information
11.3.2 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.3.3 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Precision Medical Main Business Overview
11.3.5 Precision Medical Latest Developments
11.4 Aviva Systems Biological
11.4.1 Aviva Systems Biological Company Information
11.4.2 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.4.3 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Aviva Systems Biological Main Business Overview
11.4.5 Aviva Systems Biological Latest Developments
11.5 Biocept
11.5.1 Biocept Company Information
11.5.2 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.5.3 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Biocept Main Business Overview
11.5.5 Biocept Latest Developments
11.6 Fluxion Biosciences
11.6.1 Fluxion Biosciences Company Information
11.6.2 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.6.3 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Fluxion Biosciences Main Business Overview
11.6.5 Fluxion Biosciences Latest Developments
11.7 Greiner Bio-One International GmbH
11.7.1 Greiner Bio-One International GmbH Company Information
11.7.2 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.7.3 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Greiner Bio-One International GmbH Main Business Overview
11.7.5 Greiner Bio-One International GmbH Latest Developments
11.8 Ikonisys
11.8.1 Ikonisys Company Information
11.8.2 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.8.3 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Ikonisys Main Business Overview
11.8.5 Ikonisys Latest Developments
11.9 Miltenyi Biotec
11.9.1 Miltenyi Biotec Company Information
11.9.2 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.9.3 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Miltenyi Biotec Main Business Overview
11.9.5 Miltenyi Biotec Latest Developments
11.10 IVDiagnostics
11.10.1 IVDiagnostics Company Information
11.10.2 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.10.3 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 IVDiagnostics Main Business Overview
11.10.5 IVDiagnostics Latest Developments
11.11 BioFluidica
11.11.1 BioFluidica Company Information
11.11.2 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.11.3 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 BioFluidica Main Business Overview
11.11.5 BioFluidica Latest Developments
11.12 Canopus Medical
11.12.1 Canopus Medical Company Information
11.12.2 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.12.3 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Canopus Medical Main Business Overview
11.12.5 Canopus Medical Latest Developments
11.13 Biolidics
11.13.1 Biolidics Company Information
11.13.2 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.13.3 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Biolidics Main Business Overview
11.13.5 Biolidics Latest Developments
11.14 Creativ MicroTech
11.14.1 Creativ MicroTech Company Information
11.14.2 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.14.3 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Creativ MicroTech Main Business Overview
11.14.5 Creativ MicroTech Latest Developments
11.15 LungLife AI
11.15.1 LungLife AI Company Information
11.15.2 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.15.3 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 LungLife AI Main Business Overview
11.15.5 LungLife AI Latest Developments
11.16 Epic Sciences
11.16.1 Epic Sciences Company Information
11.16.2 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.16.3 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Epic Sciences Main Business Overview
11.16.5 Epic Sciences Latest Developments
11.17 Rarecells Diagnostics
11.17.1 Rarecells Diagnostics Company Information
11.17.2 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.17.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Rarecells Diagnostics Main Business Overview
11.17.5 Rarecells Diagnostics Latest Developments
11.18 ScreenCell
11.18.1 ScreenCell Company Information
11.18.2 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.18.3 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 ScreenCell Main Business Overview
11.18.5 ScreenCell Latest Developments
11.19 Menarini Silicon Biosystems
11.19.1 Menarini Silicon Biosystems Company Information
11.19.2 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.19.3 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Menarini Silicon Biosystems Main Business Overview
11.19.5 Menarini Silicon Biosystems Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Kits & Reagents
Table 3. Major Players of Blood Collection Tubes
Table 4. Major Players of Devices
Table 5. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2023)
Table 8. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2018-2023)
Table 11. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Player (2018-2023)
Table 13. Circulating Tumor Cells (CTC) Liquid Biopsy Key Players Head office and Products Offered
Table 14. Circulating Tumor Cells (CTC) Liquid Biopsy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Regions (2018-2023)
Table 19. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Country (2018-2023)
Table 23. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2023)
Table 25. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2018-2023)
Table 27. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region (2018-2023)
Table 29. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2023)
Table 31. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2018-2023)
Table 33. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Country (2018-2023)
Table 35. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2023)
Table 37. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Circulating Tumor Cells (CTC) Liquid Biopsy
Table 46. Key Market Challenges & Risks of Circulating Tumor Cells (CTC) Liquid Biopsy
Table 47. Key Industry Trends of Circulating Tumor Cells (CTC) Liquid Biopsy
Table 48. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. QIAGEN Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 53. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 54. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. QIAGEN Main Business
Table 56. QIAGEN Latest Developments
Table 57. Bio-Techne Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 58. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 59. Bio-Techne Main Business
Table 60. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Bio-Techne Latest Developments
Table 62. Precision Medical Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 63. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 64. Precision Medical Main Business
Table 65. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Precision Medical Latest Developments
Table 67. Aviva Systems Biological Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 68. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 69. Aviva Systems Biological Main Business
Table 70. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Aviva Systems Biological Latest Developments
Table 72. Biocept Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 73. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 74. Biocept Main Business
Table 75. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Biocept Latest Developments
Table 77. Fluxion Biosciences Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 78. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 79. Fluxion Biosciences Main Business
Table 80. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Fluxion Biosciences Latest Developments
Table 82. Greiner Bio-One International GmbH Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 83. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 84. Greiner Bio-One International GmbH Main Business
Table 85. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Greiner Bio-One International GmbH Latest Developments
Table 87. Ikonisys Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 88. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 89. Ikonisys Main Business
Table 90. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Ikonisys Latest Developments
Table 92. Miltenyi Biotec Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 93. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 94. Miltenyi Biotec Main Business
Table 95. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Miltenyi Biotec Latest Developments
Table 97. IVDiagnostics Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 98. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 99. IVDiagnostics Main Business
Table 100. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. IVDiagnostics Latest Developments
Table 102. BioFluidica Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 103. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 104. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. BioFluidica Main Business
Table 106. BioFluidica Latest Developments
Table 107. Canopus Medical Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 108. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 109. Canopus Medical Main Business
Table 110. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Canopus Medical Latest Developments
Table 112. Biolidics Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 113. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 114. Biolidics Main Business
Table 115. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Biolidics Latest Developments
Table 117. Creativ MicroTech Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 118. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 119. Creativ MicroTech Main Business
Table 120. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Creativ MicroTech Latest Developments
Table 122. LungLife AI Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 123. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 124. LungLife AI Main Business
Table 125. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. LungLife AI Latest Developments
Table 127. Epic Sciences Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 128. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 129. Epic Sciences Main Business
Table 130. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Epic Sciences Latest Developments
Table 132. Rarecells Diagnostics Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 133. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 134. Rarecells Diagnostics Main Business
Table 135. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Rarecells Diagnostics Latest Developments
Table 137. ScreenCell Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 138. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 139. ScreenCell Main Business
Table 140. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. ScreenCell Latest Developments
Table 142. Menarini Silicon Biosystems Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 143. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 144. Menarini Silicon Biosystems Main Business
Table 145. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. Menarini Silicon Biosystems Latest Developments
Table 1. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Kits & Reagents
Table 3. Major Players of Blood Collection Tubes
Table 4. Major Players of Devices
Table 5. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2023)
Table 8. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2018-2023)
Table 11. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Player (2018-2023)
Table 13. Circulating Tumor Cells (CTC) Liquid Biopsy Key Players Head office and Products Offered
Table 14. Circulating Tumor Cells (CTC) Liquid Biopsy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Regions (2018-2023)
Table 19. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Country (2018-2023)
Table 23. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2023)
Table 25. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2018-2023)
Table 27. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region (2018-2023)
Table 29. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2023)
Table 31. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2018-2023)
Table 33. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Country (2018-2023)
Table 35. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2023)
Table 37. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Circulating Tumor Cells (CTC) Liquid Biopsy
Table 46. Key Market Challenges & Risks of Circulating Tumor Cells (CTC) Liquid Biopsy
Table 47. Key Industry Trends of Circulating Tumor Cells (CTC) Liquid Biopsy
Table 48. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. QIAGEN Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 53. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 54. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. QIAGEN Main Business
Table 56. QIAGEN Latest Developments
Table 57. Bio-Techne Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 58. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 59. Bio-Techne Main Business
Table 60. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Bio-Techne Latest Developments
Table 62. Precision Medical Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 63. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 64. Precision Medical Main Business
Table 65. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Precision Medical Latest Developments
Table 67. Aviva Systems Biological Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 68. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 69. Aviva Systems Biological Main Business
Table 70. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Aviva Systems Biological Latest Developments
Table 72. Biocept Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 73. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 74. Biocept Main Business
Table 75. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Biocept Latest Developments
Table 77. Fluxion Biosciences Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 78. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 79. Fluxion Biosciences Main Business
Table 80. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Fluxion Biosciences Latest Developments
Table 82. Greiner Bio-One International GmbH Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 83. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 84. Greiner Bio-One International GmbH Main Business
Table 85. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Greiner Bio-One International GmbH Latest Developments
Table 87. Ikonisys Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 88. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 89. Ikonisys Main Business
Table 90. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Ikonisys Latest Developments
Table 92. Miltenyi Biotec Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 93. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 94. Miltenyi Biotec Main Business
Table 95. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Miltenyi Biotec Latest Developments
Table 97. IVDiagnostics Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 98. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 99. IVDiagnostics Main Business
Table 100. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. IVDiagnostics Latest Developments
Table 102. BioFluidica Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 103. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 104. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. BioFluidica Main Business
Table 106. BioFluidica Latest Developments
Table 107. Canopus Medical Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 108. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 109. Canopus Medical Main Business
Table 110. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Canopus Medical Latest Developments
Table 112. Biolidics Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 113. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 114. Biolidics Main Business
Table 115. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Biolidics Latest Developments
Table 117. Creativ MicroTech Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 118. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 119. Creativ MicroTech Main Business
Table 120. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Creativ MicroTech Latest Developments
Table 122. LungLife AI Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 123. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 124. LungLife AI Main Business
Table 125. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. LungLife AI Latest Developments
Table 127. Epic Sciences Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 128. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 129. Epic Sciences Main Business
Table 130. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Epic Sciences Latest Developments
Table 132. Rarecells Diagnostics Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 133. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 134. Rarecells Diagnostics Main Business
Table 135. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Rarecells Diagnostics Latest Developments
Table 137. ScreenCell Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 138. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 139. ScreenCell Main Business
Table 140. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. ScreenCell Latest Developments
Table 142. Menarini Silicon Biosystems Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 143. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 144. Menarini Silicon Biosystems Main Business
Table 145. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. Menarini Silicon Biosystems Latest Developments
LIST OF FIGURES
Figure 1. Circulating Tumor Cells (CTC) Liquid Biopsy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Country/Region (2022)
Figure 8. Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type in 2022
Figure 10. Circulating Tumor Cells (CTC) Liquid Biopsy in Research & Academic Institutes
Figure 11. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Research & Academic Institutes (2018-2023) & ($ Millions)
Figure 12. Circulating Tumor Cells (CTC) Liquid Biopsy in Hospitals
Figure 13. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Hospitals (2018-2023) & ($ Millions)
Figure 14. Circulating Tumor Cells (CTC) Liquid Biopsy in Physician Laboratories
Figure 15. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Physician Laboratories (2018-2023) & ($ Millions)
Figure 16. Circulating Tumor Cells (CTC) Liquid Biopsy in Others
Figure 17. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application in 2022
Figure 19. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Player in 2022
Figure 20. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2018-2023 ($ Millions)
Figure 22. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2018-2023 ($ Millions)
Figure 23. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2018-2023 ($ Millions)
Figure 25. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Value Market Share by Country in 2022
Figure 26. United States Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region in 2022
Figure 31. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type in 2022
Figure 32. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application in 2022
Figure 33. China Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Country in 2022
Figure 40. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2023)
Figure 41. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2018-2023)
Figure 42. Germany Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 56. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 57. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 59. United States Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 60. Canada Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 63. China Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 64. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 65. Korea Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 67. India Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 68. Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 69. Germany Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 70. France Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 71. UK Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 72. Italy Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 73. Russia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 74. Spain Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 77. Israel Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 80. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Circulating Tumor Cells (CTC) Liquid Biopsy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Country/Region (2022)
Figure 8. Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type in 2022
Figure 10. Circulating Tumor Cells (CTC) Liquid Biopsy in Research & Academic Institutes
Figure 11. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Research & Academic Institutes (2018-2023) & ($ Millions)
Figure 12. Circulating Tumor Cells (CTC) Liquid Biopsy in Hospitals
Figure 13. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Hospitals (2018-2023) & ($ Millions)
Figure 14. Circulating Tumor Cells (CTC) Liquid Biopsy in Physician Laboratories
Figure 15. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Physician Laboratories (2018-2023) & ($ Millions)
Figure 16. Circulating Tumor Cells (CTC) Liquid Biopsy in Others
Figure 17. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application in 2022
Figure 19. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Player in 2022
Figure 20. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2018-2023 ($ Millions)
Figure 22. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2018-2023 ($ Millions)
Figure 23. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2018-2023 ($ Millions)
Figure 25. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Value Market Share by Country in 2022
Figure 26. United States Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region in 2022
Figure 31. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type in 2022
Figure 32. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application in 2022
Figure 33. China Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Country in 2022
Figure 40. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2023)
Figure 41. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2018-2023)
Figure 42. Germany Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 56. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 57. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 59. United States Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 60. Canada Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 63. China Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 64. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 65. Korea Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 67. India Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 68. Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 69. Germany Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 70. France Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 71. UK Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 72. Italy Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 73. Russia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 74. Spain Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 77. Israel Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2024-2029 ($ Millions)
Figure 80. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share Forecast by Application (2024-2029)
